These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 10546070)

  • 1. Correspondence analysis of protein kinase C (PKC) inhibition by bis-basic substituted benzamides.
    Gilbert J; Cheminant M; Bignon E; Pons M; Ojasoo T; Doré JC
    Drug Des Discov; 1998 Oct; 15(4):253-67. PubMed ID: 10546070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and protein kinase C inhibitory activities of balanol analogs with replacement of the perhydroazepine moiety.
    Lai YS; Mendoza JS; Jagdmann GE; Menaldino DS; Biggers CK; Heerding JM; Wilson JW; Hall SE; Jiang JB; Janzen WP; Ballas LM
    J Med Chem; 1997 Jan; 40(2):226-35. PubMed ID: 9003521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemical synthesis of benzamide adenine dinucleotide: inhibition of inosine monophosphate dehydrogenase (types I and II).
    Zatorski A; Watanabe KA; Carr SF; Goldstein BM; Pankiewicz KW
    J Med Chem; 1996 Jun; 39(12):2422-6. PubMed ID: 8691436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. QSAR study on tetrahydroquinoline analogues as plasmodium protein farnesyltransferase inhibitors: a comparison of rationales of malarial and mammalian enzyme inhibitory activities for selectivity.
    Gupta MK; Prabhakar YS
    Eur J Med Chem; 2008 Dec; 43(12):2751-67. PubMed ID: 18329140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactive multivariate analysis of bisindolylmaleimides as potent protein kinase C antagonists.
    Mager PP
    Drug Des Discov; 1993; 10(3):231-48. PubMed ID: 8268394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel aminophenyl benzamide-type histone deacetylase inhibitors with enhanced potency and selectivity.
    Moradei OM; Mallais TC; Frechette S; Paquin I; Tessier PE; Leit SM; Fournel M; Bonfils C; Trachy-Bourget MC; Liu J; Yan TP; Lu AH; Rahil J; Wang J; Lefebvre S; Li Z; Vaisburg AF; Besterman JM
    J Med Chem; 2007 Nov; 50(23):5543-6. PubMed ID: 17941625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peroxynitrite-induced tyrosine nitration and inhibition of protein kinase C.
    Knapp LT; Kanterewicz BI; Hayes EL; Klann E
    Biochem Biophys Res Commun; 2001 Aug; 286(4):764-70. PubMed ID: 11520063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovering benzamide derivatives as glycogen phosphorylase inhibitors and their binding site at the enzyme.
    Chen L; Li H; Liu J; Zhang L; Liu H; Jiang H
    Bioorg Med Chem; 2007 Nov; 15(21):6763-74. PubMed ID: 17719791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, antimicrobial, and QSAR studies of substituted benzamides.
    Kumar A; Narasimhan B; Kumar D
    Bioorg Med Chem; 2007 Jun; 15(12):4113-24. PubMed ID: 17428669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study of synthetic peptides derived from the PKI55 protein, a protein kinase C modulator, in human neutrophils stimulated by the methyl ester derivative of the hydrophobic N-formyl tripeptide for-Met-Leu-Phe-OH.
    Selvatici R; Falzarano S; Franceschetti L; Mollica A; Guerrini R; Siniscalchi A; Spisani S
    FEBS J; 2008 Feb; 275(3):449-57. PubMed ID: 18167144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Probing binding requirements of NAD kinase with modified substrate (NAD) analogues.
    Bonnac L; Chen L; Pathak R; Gao G; Ming Q; Bennett E; Felczak K; Kullberg M; Patterson SE; Mazzola F; Magni G; Pankiewicz KW
    Bioorg Med Chem Lett; 2007 Mar; 17(6):1512-5. PubMed ID: 17258457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and discovery of macrocyclic polyoxygenated bis-7-azaindolylmaleimides as a novel series of potent and highly selective glycogen synthase kinase-3beta inhibitors.
    Kuo GH; Prouty C; DeAngelis A; Shen L; O'Neill DJ; Shah C; Connolly PJ; Murray WV; Conway BR; Cheung P; Westover L; Xu JZ; Look RA; Demarest KT; Emanuel S; Middleton SA; Jolliffe L; Beavers MP; Chen X
    J Med Chem; 2003 Sep; 46(19):4021-31. PubMed ID: 12954055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rational design, synthesis, and structure-activity relationships of aryltriazoles as novel corticotropin-releasing factor-1 receptor antagonists.
    Lowe RF; Nelson J; Dang TN; Crowe PD; Pahuja A; McCarthy JR; Grigoriadis DE; Conlon P; Saunders J; Chen C; Szabo T; Chen TK; Bozigian H
    J Med Chem; 2005 Mar; 48(5):1540-9. PubMed ID: 15743196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Facile synthesis of non-steroidal anti-inflammatory active bisbenzamide-containing compounds.
    Girgis AS; Ellithey M
    Bioorg Med Chem; 2006 Dec; 14(24):8527-32. PubMed ID: 16973366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions between cardiac glycosides and sodium/potassium-ATPase: three-dimensional structure-activity relationship models for ligand binding to the E2-Pi form of the enzyme versus activity inhibition.
    Paula S; Tabet MR; Ball WJ
    Biochemistry; 2005 Jan; 44(2):498-510. PubMed ID: 15641774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin inhibits secretin-induced ductal secretion by activation of PKC alpha and inhibition of PKA activity.
    Lesage GD; Marucci L; Alvaro D; Glaser SS; Benedetti A; Marzioni M; Patel T; Francis H; Phinizy JL; Alpini G
    Hepatology; 2002 Sep; 36(3):641-51. PubMed ID: 12198656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The first X-ray crystal structure of the glucocorticoid receptor bound to a non-steroidal agonist.
    Madauss KP; Bledsoe RK; Mclay I; Stewart EL; Uings IJ; Weingarten G; Williams SP
    Bioorg Med Chem Lett; 2008 Dec; 18(23):6097-9. PubMed ID: 18952422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Picolinic acids as inhibitors of dopamine beta-monooxygenase: QSAR and putative binding site.
    Dove S
    Arch Pharm (Weinheim); 2004 Dec; 337(12):645-53. PubMed ID: 15597398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-inflammatory properties of a novel N-phenyl pyridinone inhibitor of p38 mitogen-activated protein kinase: preclinical-to-clinical translation.
    Hope HR; Anderson GD; Burnette BL; Compton RP; Devraj RV; Hirsch JL; Keith RH; Li X; Mbalaviele G; Messing DM; Saabye MJ; Schindler JF; Selness SR; Stillwell LI; Webb EG; Zhang J; Monahan JB
    J Pharmacol Exp Ther; 2009 Dec; 331(3):882-95. PubMed ID: 19720877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and synthesis of 3-substituted benzamide derivatives as Bcr-Abl kinase inhibitors.
    Asaki T; Sugiyama Y; Hamamoto T; Higashioka M; Umehara M; Naito H; Niwa T
    Bioorg Med Chem Lett; 2006 Mar; 16(5):1421-5. PubMed ID: 16332440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.